Catalyst Brief

← Calendar

Readoutin 14d

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — SHR-A2009 monotherapy

Phase 3 primary completion: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC.

Date
Dec 2026
Type
Readout
Indication
Non-small Cell Lung Cancer

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.